Home
Conditions
Genital Diseases, Female

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,668 public trials 1,508 recruiting studies

Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Active, Not Recruiting

Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI

NCT07509411

Conditions: Endometriosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +3 more
Locations: Benha university Banhā, El Qalyoubia, Egypt

View Trial Details

Active, Not Recruiting

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

NCT03355976

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
Locations: University of Illinois Chicago Chicago, Illinois, United States

Rhode Island Hospital Providence, Rhode Island, United States

Women & Infants Hospital Providence, Rhode Island, United States

The Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Active, Not Recruiting

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

NCT06342986

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

NCT03614949

Conditions: Cervical Cancer, Cervical Cancer Metastatic, Cervical Cancer Recurrent, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Ohio State University - OSUMC - Wexner Medical Center Hilliard, Ohio, United States

View Trial Details

Active, Not Recruiting

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

NCT05605535

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Omega Hospitals Visakhapatnam, Andhra Pradesh, India

King George Hospital Visakhapatnam, Andhra Pradesh, India

Himalaya Cancer Hospital and Research Institute Vadodara, Gujarat, India

Kailash Cancer Hospital and Research Centre Vadodara, Gujarat, India

View all 14 locations

View Trial Details

Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions: Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations: Honor Health Phoenix, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

John Muir Health Clinical Research Center Concord, California, United States

Kaiser Permanente Southern California Irvine, California, United States

View all 148 locations

View Trial Details

Active, Not Recruiting

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

NCT02873962

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

NCT05645146

Conditions: Behavior, Cervical Cancer, Female Urogenital Diseases, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Predictive Clinical and Biological Parameters in Gynecological Cancer

NCT01977274

Conditions: Adnexal Diseases, Cervix Cancer, Endocrine Gland Neoplasms, +20 more
Locations: Institut Paoli Calmettes Marseille, France

View Trial Details

Active, Not Recruiting

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

NCT05514028

Conditions: Adnexal Diseases, Borderline Ovarian Cancer, Endocrine Gland Neoplasms, +15 more
Locations: CHU de Caen Caen, Calvados, France

CGFL Dijon, Côte d'Or, France

Institut Bergonié Bordeaux, Gironde, France

CHU Strasbourg Strasbourg, Haut-Rhin, France

View all 21 locations

View Trial Details

Genital Diseases, Female

Genital Diseases, Female trial results

Related conditions